Spark Therapeutics Inc (ONCE)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jeffrey D. Marrazzo
Employees:
368
3737 MARKET STREET, SUITE 1300, PHILADELPHIA, PA 19104
888-772-7560

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Spark Therapeutics, Inc. engages in gene therapy research, development, manufacturing and clinical trials. The company is developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases. Its initial focus is on treating orphan diseases, and it has demonstrated promising clinical outcomes with its first product candidate targeting rare blinding conditions, which has received both breakthrough therapy and orphan product designation and is in a fully enrolled, pivotal Phase 3 clinical trial. The company also has built a pipeline of product candidates targeting additional blinding conditions, hematologic disorders and neurodegenerative diseases, including a second product candidate targeting another rare blinding condition. Spark Therapeutics was founded by Jeffrey D. Marrazzo, Katherine A. High and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.

Data derived from most recent annual or quarterly report
Market Cap 4.371 Billion Shares Outstanding38.49 Million Avg 30-day Volume 545.792 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-4.81
Price to Revenue53.4645 Debt to Equity0.1421 EBITDA-240.712 Million
Price to Book Value10.7974 Operating Margin-358.24150000000003 Enterprise Value3.355 Billion
Current Ratio4.666 EPS Growth-2.13 Quick Ratio4.241
1 Yr BETA 1.0098 52-week High/Low 0.0 / Profit Margin-358.4061
Operating Cash Flow Growth-161.0033 Altman Z-Score4.2799 Free Cash Flow to Firm -158.195 Million
View SEC Filings from ONCE instead.

View recent insider trading info

Funds Holding ONCE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONCE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-12-17:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-19:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-23:
    Item 8.01: Other Events
  • 8-K: filed on 2018-11-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-11-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-23:
    Item 2.01: Completion of Acquisition or Disposition of Assets
  • 8-K: filed on 2018-05-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ROCHE HOLDINGS INC

    ROCHE HOLDING LTD

    • 10% Owner
    29,746,673 2019-12-17 0

    MILANO VINCENT

    • Director
    No longer subject to file 2019-12-17 0

    SIGAL ELLIOT

    • Director
    No longer subject to file 2019-12-17 0

    PEREZ ROBERT J

    • Director
    No longer subject to file 2019-12-17 0

    ZOTH LOTA S. CHIEF SCIENTIFIC OFFICER

    • Officer
    • Director
    No longer subject to file 2019-12-17 0

    EKMAN LARS

    • Director
    No longer subject to file 2019-12-17 0

    WEBSTER STEPHEN W CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2019-12-17 0

    ALTSCHULER STEVEN

    • Director
    No longer subject to file 2019-12-17 0

    MEHRA ANAND

    • Director
    No longer subject to file 2019-12-17 0

    HIGH KATHERINE A SEE REMARKS

    • Officer
    • Director
    No longer subject to file 2019-12-17 0

    MARRAZZO JEFFREY D CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    No longer subject to file 2019-12-17 0

    LA BARGE JOSEPH CHIEF LEGAL OFFICER

    • Officer
    No longer subject to file 2019-12-17 0

    FAGA DANIEL CHIEF BUSINESS OFFICER

    • Officer
    No longer subject to file 2019-12-17 0

    MINGOZZI FEDERICO CHIEF SCIENTIFIC OFFICER

    • Officer
    No longer subject to file 2019-12-17 0

    DALTON LISA CHIEF HUMAN RESOURCE OFFICER

    • Officer
    No longer subject to file 2019-12-17 0

    LA BARGE JOSEPH CHIEF LEGAL OFFICER

    LA BARGE JOSEPH CHIEF LEGAL OFFICER

    • Officer
    21,882 2019-03-19 0

    CHILDREN'S HOSPITAL OF PHILADELPHIA FOUNDATION

    • 10% Owner
    No longer subject to file 2019-02-27 0

    FUREY JOHN CHIEF OPERATING OFFICER

    • Officer
    0 2018-04-20 0

    BETZ ALERT LORRIS

    • Director
    0 2017-05-31 0

    VIVALDI COELHO ROGERIO CHIEF COMMERCIAL OFFICER

    • Officer
    18,716 2016-07-15 0

    MEHRA ANAND

    SOFINNOVA VENTURE PARTNERS VIII, L.P.

    SOFINNOVA MANAGEMENT VIII, L.L.C.

    AKKARAJU SRINIVAS

    HEALY JAMES

    POWELL MICHAEL

    • Director
    • 10% Owner
    0 2015-01-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments